Alternatives to Treatment with Minor Tranquilizers in Psychogeriatrics

  • Thomas A. Ban


There has been an unprecedented rapid increase in average life expectancy at birth during the past 100 years. As a result, of the three billion people living today, over 200 million are aged (Ban, 1980).


Anxiety Disorder Alternative Treatment Modality Minor Tranquilizer Neurotic Disorder Monoamine Content 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Balier, C., 1968, Les etats nevrotiques chez les personnes agees, Gaz. med. F., 75: 3415–3416.Google Scholar
  2. Ban, T. A., 1980, Psychopharmacology for the Aged, Karger, Basel.Google Scholar
  3. Ban, T. A. and Prakash, R., 1983, Anxiolytics: clinical perspectives. In Malick, J. B., Enna, S. J. and Yamamura, H. I. (eds): Anxiolytics; Neurochemical, Behavioral and Clinical Perspectives, Raven Press, New York.Google Scholar
  4. Bergman, K., 1975, The neuroses of old age, Brit. J. Psychiat., 25 ( Spec. No. 9 ): 100–109.Google Scholar
  5. Brunner, H., Hedwall, P. R. and Meier, M., 1967, Influence of adrenergic beta–receptor blockage on the acute cardiovascular effects of hydralazine, Brit. J. Pharmacol., 30: 123–133.PubMedGoogle Scholar
  6. Gruenberg, E. M., 1961, A mental health survey of older persons. In Hoch, P. and Zubin, J. (eds): Comparative Epidemiology of Mental Disorders, Grune and Stratton, New York.Google Scholar
  7. Itil, T. M., Herrmann, W. M., Blasucci, D. and Freedman, A., 1978, Male hormones in the treatment of depression. Effects of mesterolone, Prog. Neuro–Psychopharmacol., 2: 457–467.CrossRefGoogle Scholar
  8. Kathol, R. G., Noyes, R., Jr., Slymen, D. J. et al., 1980, Propranolol in chronic anxiety disorders. A controlled study. Read at the American Psychopathological Association Meeting, Washinqton, March.Google Scholar
  9. Kielholz, P., Poldinger, W. and Adams, C., 1982, Masked Depression, Deutscher Aerzte-Verlag, Koln.Google Scholar
  10. Klein, D. F., 1973, Drug therapy as a means of syndromal identification and nosological revision. In Cole, J. O., Freeman, A. M. and Friedhoff, A. J. (eds): Psychopathology and Psychopharmacology, Johns Hopkins University Press, Baltimore.Google Scholar
  11. Kral, V. A. and Wigdor, B. T., 1959, Androgen effect on senescent memory function, Geriatrics, 14: 450–456.Google Scholar
  12. Kurtland, M., 1979, Organic brain syndrome with propranolol, N. Eng. J. Med., 300: 366–367.Google Scholar
  13. McClelland, H. A., 1973, Psychiatric complications of drug therapy, Adv. Drug React. Bull., 40: 128–129.CrossRefGoogle Scholar
  14. Pakesch, E., 1967, Zum Syndrom der larvierten Depression. In Kranz, H. and Heinrich, K. (eds): Pharmakopsychiatrie and Psychopathologie, Thieme, Stuttgart.Google Scholar
  15. Raskin, A., Robinson, D. and Levine J. (eds), 1981, Age and the Pharmacology of Psychoactive Drugs, Elsevier, Admsterdam.Google Scholar
  16. Salzman, C., Shader, R. I. and Harmatz, J. S., 1975, Reponse of the elderly to psychotropi c drugs.Predictable or idiosyncratic? In Gershon, S. and Raskin, A (eds): Aging, Vol. 2, Raven Press, New York.Google Scholar
  17. Snyder, S., 1980, Amitriptyline therapy of obsessive-compulsive neurosis, J. Clin. Psychiat., 41: 286–289.Google Scholar
  18. Szobor, A., 1965, Contribution au traitement des affections cerebrovasculaires, Ther. Hung, 13: 3–105.Google Scholar
  19. Thoren, P., Asberg, M. and Bertilsson, L., 1980b, Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects, Arch. Gen. Psychiatry, 37: 1289–1296.Google Scholar
  20. Thoren, P., Asberg, M. and Cronholm, B., 1980a, Clomipramine treatment of obsessive-compulsive disorder. I. A controlled trial, Arch. Gen. Psychiatry, 37: 1281–1285.PubMedGoogle Scholar
  21. Tyrer, P., 1976, Towards rational therapy with monoamine oxidase inhibitors, Brit. J. Psychiat., 128: 354–360.PubMedCrossRefGoogle Scholar
  22. Waal, H. J., 1968, Hypotensive, antiarrhythmic and chronotropic action of Trasicor (CIBA 39,089 Ba), N.Z. Med. J., 67: 291–295.PubMedGoogle Scholar
  23. Walcher, W., 1969, Die Larvierte Depression, Hollinek, Vienna.Google Scholar
  24. Yaryura-Tobias, J. A. and Bhagavan, N., 1977, Tryptophan in obsessive-compulsive neurosis, Am. J. Psychiat., 134: 11–12.Google Scholar
  25. Yaryura-Tobias, J. A., Neziroglu, F. and Bergman, L., 1976, Chlorimipramine for obsessive-compulsive neurosis: an organic approach, Curr. Therap. Res., 20: 541–548.Google Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Thomas A. Ban
    • 1
  1. 1.Department of PsychiatryVanderbilt UniversityNashvilleUSA

Personalised recommendations